These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 22836147)
1. Scar-mediated inhibition and CSPG receptors in the CNS. Sharma K; Selzer ME; Li S Exp Neurol; 2012 Oct; 237(2):370-8. PubMed ID: 22836147 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of scar-sourced axon growth inhibitors. Ohtake Y; Li S Brain Res; 2015 Sep; 1619():22-35. PubMed ID: 25192646 [TBL] [Abstract][Full Text] [Related]
3. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. Dyck S; Kataria H; Alizadeh A; Santhosh KT; Lang B; Silver J; Karimi-Abdolrezaee S J Neuroinflammation; 2018 Mar; 15(1):90. PubMed ID: 29558941 [TBL] [Abstract][Full Text] [Related]
4. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. Fisher D; Xing B; Dill J; Li H; Hoang HH; Zhao Z; Yang XL; Bachoo R; Cannon S; Longo FM; Sheng M; Silver J; Li S J Neurosci; 2011 Oct; 31(40):14051-66. PubMed ID: 21976490 [TBL] [Abstract][Full Text] [Related]
5. Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury. Xu B; Park D; Ohtake Y; Li H; Hayat U; Liu J; Selzer ME; Longo FM; Li S Neurobiol Dis; 2015 Jan; 73():36-48. PubMed ID: 25220840 [TBL] [Abstract][Full Text] [Related]
7. Regulation of autophagy by inhibitory CSPG interactions with receptor PTPσ and its impact on plasticity and regeneration after spinal cord injury. Tran AP; Warren PM; Silver J Exp Neurol; 2020 Jun; 328():113276. PubMed ID: 32145250 [TBL] [Abstract][Full Text] [Related]
14. Suppressing CSPG/LAR/PTPσ Axis Facilitates Neuronal Replacement and Synaptogenesis by Human Neural Precursor Grafts and Improves Recovery after Spinal Cord Injury. Hosseini SM; Alizadeh A; Shahsavani N; Chopek J; Ahlfors JE; Karimi-Abdolrezaee S J Neurosci; 2022 Apr; 42(15):3096-3121. PubMed ID: 35256527 [TBL] [Abstract][Full Text] [Related]
15. Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors. Sami A; Selzer ME; Li S Front Cell Neurosci; 2020; 14():174. PubMed ID: 32714150 [TBL] [Abstract][Full Text] [Related]
16. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase. Moon LD; Asher RA; Fawcett JW J Neurosci Res; 2003 Jan; 71(1):23-37. PubMed ID: 12478611 [TBL] [Abstract][Full Text] [Related]
17. Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system. Dyck SM; Karimi-Abdolrezaee S Exp Neurol; 2015 Jul; 269():169-87. PubMed ID: 25900055 [TBL] [Abstract][Full Text] [Related]
18. A new role for RPTPsigma in spinal cord injury: signaling chondroitin sulfate proteoglycan inhibition. Duan Y; Giger RJ Sci Signal; 2010 Feb; 3(110):pe6. PubMed ID: 20179269 [TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Lemons ML; Howland DR; Anderson DK Exp Neurol; 1999 Nov; 160(1):51-65. PubMed ID: 10630190 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Lang BT; Cregg JM; DePaul MA; Tran AP; Xu K; Dyck SM; Madalena KM; Brown BP; Weng YL; Li S; Karimi-Abdolrezaee S; Busch SA; Shen Y; Silver J Nature; 2015 Feb; 518(7539):404-8. PubMed ID: 25470046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]